UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000060534
Receipt number R000069247
Scientific Title Survey on the Understanding of Placebos in Japan
Date of disclosure of the study information 2026/01/31
Last modified on 2026/01/31 11:58:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Survey on the Understanding of Placebos in Japan

Acronym

Survey on the Understanding of Placebos

Scientific Title

Survey on the Understanding of Placebos in Japan

Scientific Title:Acronym

Survey on the Understanding of Placebos

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the general Japanese population's level of knowledge about placebo and the placebo effect, their preference for explanations, and their willingness and acceptance of placebo use in treatment.

Basic objectives2

Others

Basic objectives -Others

Comparison with a previous study (Dutch-speaking population)

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Knowledge and Acceptability Scores of Placebos

Key secondary outcomes

Placebo Quiz score, willingness to participate in each treatment, responses for preferring specific explanations of placebo effects
Optimism and pessimism scores, Five-factor model of personality, Trait anxiety


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Healthy adults aged 18 years or older.
Native Japanese speakers with the ability to understand and respond in Japanese.

Key exclusion criteria

No specific exclusion criteria were defined.

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Yoshiyuki
Middle name
Last name Hirano

Organization

Chiba University

Division name

Research Center for Child Mental Development

Zip code

260-8670

Address

1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba

TEL

043-226-2975

Email

hirano@chiba-u.jp


Public contact

Name of contact person

1st name Yasuka
Middle name
Last name Sahara

Organization

Chiba University

Division name

Graduate School of Medicine Cogntive Behavioral Physiology

Zip code

260-8670

Address

1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba

TEL

043-226-2027

Homepage URL


Email

22fd0144@student.gs.chiba-u.jp


Sponsor or person

Institute

Chiba University

Institute

Department

Personal name



Funding Source

Organization

Chiba University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research ethics committee of Chiba University

Address

1-8-1Inohaba, Chuo-ku, Chiba, Chiba

Tel

043-251-1111

Email

inohana-rinri@chiba-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 01 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 01 Month 21 Day

Date of IRB


Anticipated trial start date

2026 Year 02 Month 01 Day

Last follow-up date

2026 Year 02 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observational study
Web-based questionnaire survey


Management information

Registered date

2026 Year 01 Month 31 Day

Last modified on

2026 Year 01 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069247